Filing Details
- Accession Number:
- 0001179110-10-013921
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-17 09:15:40
- Reporting Period:
- 2010-09-16
- Filing Date:
- 2010-09-17
- Accepted Time:
- 2010-09-17 09:15:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 744218 | Celldex Therapeutics Inc. | CLDX | In Vitro & In Vivo Diagnostic Substances (2835) | 133191702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1338185 | Andrew Thomas Davis | C/O Celldex Therapeutics, Inc. 119 Fourth Avenue Needham MA 02494 | Sr. Vp & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-09-16 | 1,489 | $3.77 | 1,489 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2010-09-16 | 1,011 | $3.78 | 1,011 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
